From: Influence of Staphylococcus aureus on Outcomes after Valvular Surgery for Infective Endocarditis
Univariable | Multivariable | |||
---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Staph Aureus | 1.20 (0.50–2.85) | 0.68 | ||
Male gender | 0.87 (0.38–1.96) | 0.73 | ||
Body Mass Index | 1.03 (0.96–1.10) | 0.43 | ||
Age at surgery | 1.01 (0.98–1.03) | 0.56 | ||
Prior cardiac surgery | 0.99 (0.45–2.20) | 0.99 | ||
Prior PCI | 2.17 (0.69–6.82) | 0.19 | 1.91 (0.54–6.77) | 0.32 |
History of CHF | 1.49 (0.68–3.29) | 0.32 | ||
Hypertension | 0.90 (0.40–2.00) | 0.79 | ||
Diabetes | 1.47 (0.62–3.50) | 0.39 | ||
Previous CVA | 1.12 (0.47–2.65) | 0.80 | ||
MI | ||||
> 21 days | 1.48 (0.48–4.59) | 0.49 | ||
≤ 21 days | 0.96 (0.12–7.72) | 0.97 | ||
Arrythmia | 0.68 (0.28–1.65) | 0.39 | ||
ESRD | 2.99 (1.17–7.64) | 0.02 | 2.57 (0.58–11.47) | 0.22 |
Chronic lung disease | 0.71 (0.16–3.14) | 0.65 | ||
PAD | 1.56 (0.43–5.58) | 0.50 | ||
Valve replacement within 5 years | 0.94 (0.37–2.42) | 0.90 | ||
eGFR < 30 | 1.89 (0.79–4.54) | 0.16 | 1.25 (0.32–4.90) | 0.75 |
Left ventricular ejection fraction | 0.97 (0.94–1.00) | 0.06 | 0.97 (0.93–1.00) | 0.05 |
Abscess | 0.61 (0.24–1.57) | 0.31 | ||
Large vegetation (>10 mm) | 5.65 (2.04–15.67) | 0.001 | 5.37 (1.90–15.20) | 0.002 |
New/Worsened heart failure | 1.33 (0.58–3.00) | 0.50 | ||
Persistent bacteremia | 1.70 (0.73–3.96) | 0.22 |